HIV-associated lymphoma: Promising new results, but with toxicity Journal Article


Author: Straus, D. J.
Article Title: HIV-associated lymphoma: Promising new results, but with toxicity
Abstract: Treatment of HIV-associated non-Hodgkin lymphoma with rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide resulted in high complete remission and 2-year failure-free and overall survival rates but a high rate of infection.
Keywords: survival rate; prednisone; clinical trial; mortality; review; doxorubicin; chemotherapy; rituximab; infection; bone marrow; etoposide; cyclophosphamide; vincristine; b cell lymphoma; immune response; remission; human immunodeficiency virus; highly active antiretroviral therapy; infection rate
Journal Title: Blood
Volume: 105
Issue: 5
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2005-03-01
Start Page: 1842
Language: English
DOI: 10.1182/blood-2004-12-4729
PROVIDER: scopus
PUBMED: 15747398
DOI/URL:
Notes: --- - "Cited By (since 1996): 12" - "Export Date: 24 October 2012" - "CODEN: BLOOA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David J Straus
    356 Straus